VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A compendium of potential biomarkers of pancreatic cancer.
Oligonucleotide microarray analysis of aminoallyl-labeled cDNA targets from linear RNA amplification.
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
Two-dimensional gel electrophoresis of cellular proteins reveals myeloid origin of blasts in two children with otherwise undifferentiated leukemia.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med. 2014 Jan 23; 370(4):311-21.
View in:
PubMed
subject areas
Activities of Daily Living
Aged
Aged, 80 and over
Alzheimer Disease
Amyloid beta-Peptides
Antibodies, Monoclonal, Humanized
Apolipoproteins E
Biomarkers
Cognition
Double-Blind Method
Female
Humans
Intention to Treat Analysis
Male
Neuropsychological Tests
Severity of Illness Index
tau Proteins
Treatment Failure
authors with profiles
Xiaoying Sun
RACHELLE DOODY